Citations 1-10 of 13 total displayed.
Most recent content
(14 Jul 2008):
-
- News
- News feature: Costly US anticancer drugs pose problems for doctors and patients
- Fred Charatan
-
BMJ 2008;337:a778, doi: 10.1136/bmj.a778, (Published 14 July 2008)
-
[Extract]
[Full text]
-
- Letters
- Critical issue is rapidity of review of new drugs
- Alan Rodger
-
BMJ 2008;337:a779, doi: 10.1136/bmj.a779, (Published 14 July 2008)
-
[Extract]
[Full text]
-
- Minerva
-
- Victoria H Smith and Stephen K Jones
-
BMJ 2008;337:a793, doi: 10.1136/bmj.a793, (Published 14 July 2008)
-
[Full text]
-
- Letters
- Why not adopt the blacklist of yore?
- L Sam Lewis
-
BMJ 2008;337:a807, doi: 10.1136/bmj.a807, (Published 14 July 2008)
-
[Extract]
[Full text]
Past content
(since Jun 2008):
-
- Minerva
-
- Susannah Hoey, Sai Yee Chuah, Helen Poole, and Sam Allen
-
BMJ 2008;337:a587, doi: 10.1136/bmj.a587, (Published 3 July 2008)
-
[Full text]
-
- Editor's choice
- The NHS in our hands
- Fiona Godlee
-
BMJ 2008;337:a663, doi: 10.1136/bmj.a663, (Published 2 July 2008)
-
[Extract]
[Full text]
-
- Practice
- Fatal reactivation of hepatitis B after chemotherapy for lymphoma
- Richard Dillon, Gideon M Hirschfield, Michael E D Allison, and Kanchan P Rege
-
BMJ 2008;337:a423, doi: 10.1136/bmj.39490.680498.BE, (Published 1 July 2008)
-
[Extract]
[Full text]
-
- Editorials
- Drugs for cancer and copayments
- Ilora Finlay and Nigel Crisp
-
BMJ 2008;337:a527, doi: 10.1136/bmj.a527, (Published 30 June 2008)
-
[Extract]
[Full text]
-
- Views & reviews
- Top-ups for cancer drugs: can we kill the zombie for good?
- Cam Donaldson
-
BMJ 2008;337:a578, doi: 10.1136/bmj.a578, (Published 30 June 2008)
-
[Extract]
[Full text]
-
- News
- NHS might have to attract more private money if it is to improve standards
- Rebecca Coombes
-
BMJ 2008;336:1457, doi: 10.1136/bmj.a440,
-
[Extract]
[Full text]
[PDF]